Skip to main content

Explore Discussions

Join conversations that matter to you

Start a Discussion
Culture

Wednesday assorted links

1. Some Kevin Grier biohistory (for the bots?). 2. Andrej. 3. Joshua Rothman on the new Knausgaard cycle (New Yorker). 4. New Substack and podcast Ideas in Development. 5. “Introducing Prism, a free workspace for scientists to write and collaborate on research, 2.” 6. Art De Vany, RIP. 7. “Indische Beschäftigte verdienen weiterhin […] The post Wednesday assorted links appeared first on Marginal REVOLUTION. CommentsAnyone who thinks that big corporate media isn't just shilling . by Action Figu...

Global
Join Discussion
Business

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

a16z general partner Jorge Conde talks with Vasant Narasimhan, CEO of Novartis International, about transforming a 250-year-old conglomerate into a pure play medicines company and unlocking $180 billion of value in the process. They cover Novartis's platform technologies: cell and gene therapies, RNA medicines, and radioligand therapies. They also discuss AI in drug discovery, the rise of China as a biotech competitor, and what Vasant looks for when evaluating startup partnerships, including ...

Global
Join Discussion